In this interactive case study, you will prepare for a tumor board discussion that will determine whether your patient is a candidate for biomarker testing and eligible for biomarker-directed therapy. To be able to contribute to and understand the discussion, you will need to learn various genomic terms and concepts. Learning checkpoints will be encountered throughout the case study to test your knowledge.
The duration of this case study is approximately 30 minutes. This course does not provide Nursing Continuing Professional Development (NCPD).
You will enjoy access for 90 days from date of purchase, after which you will no longer be able to access the course.
This case study was developed by ONS through a sponsorship from AstraZeneca. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications.
The learning outcome for this course is that the learner will understand various genomic terms and concepts to comprehend a tumor board discussion.
Oncology nurses, including point-of-care, care coordinators, advanced practice nurses and nurse navigators.